23andMe Bankruptcy: Understanding Customer Rights and Data Protection

23andMe Files for Bankruptcy

• 🧬 23andMe, a genetic testing company, has filed for Chapter 11 bankruptcy protection as it seeks to restructure and sell off its assets.
• 📉 The co-founder and CEO, Anne Wojcicki, has stepped down following a failed bid to take the company private.

Sale of Customer Data

• 💰 The company's database, containing genetic information from over 15 million customers, is a valuable asset and could potentially be sold as part of the bankruptcy proceedings.
• ⚠️ Any buyer of the data would be required to comply with applicable privacy laws, but they could also change the privacy policy after acquisition, requiring customer agreement.

Data Protection and Vulnerability

• 🔒 While bankruptcy is a public process, it offers some protections for customer data, allowing regulators like the FTC and state attorneys general to object to the handling of data.
• ⚖️ A consumer privacy ombudsman could be appointed to investigate asset sales and ensure compliance with privacy policies and laws.
• 📢 The California Attorney General has warned users to delete their data and have their genetic samples destroyed, emphasizing consumers' right to direct the deletion of their genetic information.

Customer Rights and Future Guidance

• 💡 Customers have the right to delete their account or revoke permission for their genetic data to be used in research if they are uncomfortable with the situation.
• 📜 While the company's privacy policy may permit the transfer of personal information in a bankruptcy sale, customers should be aware of the potential implications.
• 🚨 There is a call for more federal guidance and protections regarding user data when direct-to-consumer genetic testing companies go bankrupt, as current protections are not as robust as those for healthcare providers (e.g., HIPAA).